Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MDPediatrix Medical Group, Inc.

NYSE · CIK 0000893949
Filer categoryLarge accelerated filer
Entity typeoperating
SIC8060 Services-Hospitals
FY end1231
XBRL facts536

Identity from submissions API

NamePediatrix Medical Group, Inc.
CIK0000893949
TickersMD
ExchangesNYSE
Entity typeoperating
CategoryLarge accelerated filer
SIC8060 Services-Hospitals
EIN263667538
LEI—
Fiscal year end1231
State of incorporationFL FL
Phone9543840175
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • MEDNAX, INC. (2008-12-22T05:00:00.000Z → 2022-06-21T04:00:00.000Z)
  • PEDIATRIX MEDICAL GROUP INC (1996-08-08T04:00:00.000Z → 2009-01-02T05:00:00.000Z)
Business address
1301 CONCORD TERRACE
SUNRISE
FL
33323
FL
Mailing address
1301 CONCORD TERRACE
SUNRISE
FL
33323
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1475 filing rows loaded from submissions recent; extra archives: CIK0000893949-submissions-001.json (473 filings, 1996-05-10 to 2009-05-31).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-10-29 10-Q 10-Q 0001193125-26-436952 001-12111 261497394 34 7155119 1 1
2026-10-29 8-K 8-K 2.02,9.01 0001193125-26-436932 001-12111 261497354 34 1684851 1 1
2026-09-14 144 xsl144X01/primary_doc.xml 0001628280-26-061930 001-12111 261378626 33 9200
2026-09-14 144 xsl144X01/primary_doc.xml 0001628280-26-061929 001-12111 261378625 33 7906
2026-09-14 4 4 0001193125-26-390731 4657
2026-09-10 144 xsl144X01/primary_doc.xml 0001628280-26-061367 001-12111 261371436 33 4718
2026-09-03 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-001021 005-46595 261358076 34 8017
2026-09-03 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001530 005-46595 261358013 34 8071
2026-09-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002720 005-46595 261357781 34 7843
2026-08-18 4 4 0001193125-26-355656 5206
2026-08-14 144 xsl144X01/primary_doc.xml 0001628280-26-057186 001-12111 261283997 33 5279
2026-08-14 4 4 0001193125-26-352534 5793
2026-08-14 4 4 0001193125-26-352532 4871
2026-08-14 4 4 0001193125-26-352531 4940
2026-08-14 4 4 0001193125-26-352527 4958
2026-08-14 4 4 0001193125-26-352528 4876
2026-08-14 4 4 0001193125-26-352526 4931
2026-08-14 4 4 0001193125-26-352524 4930
2026-08-14 4 4 0001193125-26-352522 4975
2026-08-04 10-Q 10-Q 0001193125-26-331513 001-12111 261235387 34 6767322 1 1
2026-08-04 8-K 8-K 2.02,9.01 0001193125-26-331488 001-12111 261235362 34 1638210 1 1
2026-07-24 8-K 8-K 5.02,7.01 0001193125-26-316225 001-12111 261202191 34 929125 1 1
2026-07-15 8-K 8-K 2.02,7.01,9.01 0001193125-26-304033 001-12111 261175846 34 1212608 1 1
2026-07-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000354204-26-000805 005-46595 261173606 34 8779
2026-06-24 4 4 0001193125-26-281304 7864
2026-06-24 3 3 0001193125-26-281238 20218
2026-06-10 4 4 0001193125-26-266014 6819
2026-06-03 4 4 0001193125-26-255710 6720
2026-06-03 4 4 0001193125-26-255705 10518
2026-06-03 4 4 0001193125-26-255704 6730
2026-06-03 4 4 0001193125-26-255703 5827
2026-05-21 S-8 S-8 0001193125-26-234596 333-296121 261009110 33 330403 1 1
2026-05-14 4 4 0001193125-26-224280 6173
2026-05-14 4 4 0001193125-26-224279 6610
2026-05-13 144 xsl144X01/primary_doc.xml 0000905148-26-002256 001-12111 26975385 33 6969
2026-05-13 4 4 0001193125-26-221884 5973
2026-05-11 4 4 0001193125-26-217256 4909
2026-05-11 4 4 0001193125-26-217253 4936
2026-05-11 4 4 0001193125-26-217242 21234
2026-05-11 4 4 0001193125-26-217235 21191
2026-05-11 4 4 0001193125-26-217234 21213
2026-05-11 4 4 0001193125-26-217227 22156
2026-05-11 4 4 0001193125-26-217222 22060
2026-05-11 4 4 0001193125-26-217219 4854
2026-05-07 8-K 8-K 5.02,5.07,9.01 0001193125-26-212117 001-12111 26954049 34 1036919 1 1
2026-05-05 10-Q 10-Q 0001193125-26-204993 001-12111 26940352 34 6042844 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001193125-26-204982 001-12111 26940307 34 1475153 1 1
2026-04-17 DEFA14A DEFA14A 0001193125-26-161594 001-12111 26871852 34 137202
2026-03-27 ARS ARS 0001193125-26-127316 001-12111 26800989 34 1290374
2026-03-27 DEFA14A DEFA14A 0001193125-26-127310 001-12111 26800974 34 1921289
2026-03-27 DEF 14A DEF 14A 0001193125-26-127299 001-12111 26800965 34 27514435 1 1
2026-03-03 4 4 0001193125-26-088621 7307
2026-03-03 4 4 0001193125-26-088620 4697
2026-02-19 10-K 10-K 0001193125-26-058074 001-12111 26651443 34 13915540 1 1
2026-02-19 8-K 8-K 2.02,9.01 0001193125-26-058063 001-12111 26651431 34 1701013 1 1
2025-12-17 4 4 0001193125-25-322897 21617
2025-12-15 144 xsl144X01/primary_doc.xml 0001967940-25-000094 001-12111 251572126 33 5012
2025-11-19 4 4 0001193125-25-288277 21361
2025-11-17 144 xsl144X01/primary_doc.xml 0000905148-25-004105 001-12111 251492360 33 5367
2025-11-10 4 4 0001193125-25-274502 21409
2025-11-06 144 xsl144X01/primary_doc.xml 0001628280-25-050236 001-12111 251458953 33 4962
2025-11-03 10-Q 10-Q 0001193125-25-261640 001-12111 251442068 34 6982126 1 1
2025-11-03 8-K 8-K 2.02,9.01 0001193125-25-261626 001-12111 251442053 34 1692708 1 1
2025-08-21 4 4 0000950170-25-110715 7270
2025-08-18 8-K 8-K 7.01,8.01,9.01 0000950170-25-109777 001-12111 251228470 34 1191145 1 1
2025-08-05 4 4 0000950170-25-103206 7731
2025-08-05 3 3 0000950170-25-103197 20977
2025-08-05 4 4 0000950170-25-103196 4721
2025-08-05 10-Q 10-Q 0000950170-25-102382 001-12111 251182729 34 6814338 1 1
2025-08-05 8-K 8-K 2.02,9.01 0000950170-25-102375 001-12111 251182708 34 1665863 1 1
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003090 005-46595 251132266 34 11105
2025-07-01 3 3 0000950170-25-092308 18895
2025-07-01 8-K 8-K 5.02,7.01,9.01 0000950170-25-092261 001-12111 251096836 34 1189580 1 1
2025-06-12 4 4 0000950170-25-085534 5838
2025-06-03 4 4 0000950170-25-081079 6571
2025-06-03 4 4 0000950170-25-081078 5068
2025-06-03 4 4 0000950170-25-081076 7562
2025-06-03 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001532155-25-000121 005-46595 251019783 34 7676
2025-05-27 4 4 0000950170-25-077830 5602
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001532155-25-000099 005-46595 25947016 34 7653
2025-05-12 4 4 0000950170-25-069435 4776
2025-05-12 4 4 0000950170-25-069434 4804
2025-05-12 4 4 0000950170-25-069433 4715
2025-05-12 4 4 0000950170-25-069432 4777
2025-05-12 4 4 0000950170-25-069431 5742
2025-05-12 4 4 0000950170-25-069430 4821
2025-05-12 4 4 0000950170-25-069429 4786
2025-05-12 4 4 0000950170-25-069428 4721
2025-05-08 8-K 8-K 5.07 0000950170-25-067076 001-12111 25926761 34 1014914 1 1
2025-05-06 10-Q 10-Q 0000950170-25-063951 001-12111 25915170 34 5574451 1 1
2025-05-06 8-K 8-K 2.02,9.01 0000950170-25-063946 001-12111 25915157 34 1480306 1 1
2025-04-18 8-K 8-K 1.01 0000950170-25-055880 001-12111 25850654 34 933601 1 1
2025-03-28 ARS ARS 0000950170-25-046330 001-12111 25781432 34 10839014
2025-03-28 DEFA14A DEFA14A 0000950170-25-046328 001-12111 25781430 34 1141093
2025-03-28 DEF 14A DEF 14A 0000950170-25-046327 001-12111 25781427 34 32877733 1 1
2025-03-07 4 4 0000950170-25-035657 5887
2025-03-04 4 4 0000950170-25-032358 5695
2025-03-04 4 4 0000950170-25-032354 4704
2025-02-26 4 4 0000950170-25-027891 5612
2025-02-21 144 xsl144X01/primary_doc.xml 0001965353-25-000030 001-12111 25652790 33 4370
2025-02-20 10-K 10-K 0000950170-25-023730 001-12111 25643220 34 14000035 1 1
2025-02-20 8-K 8-K 2.02,9.01 0000950170-25-023723 001-12111 25643204 34 1676673 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-012913 005-46595 25620006 34 10479
2025-01-14 4 4 0000950170-25-005487 5824
2025-01-14 8-K 8-K 5.02 0001193125-25-006190 001-12111 25529703 34 189275 1 1
2025-01-13 8-K 8-K 2.02,7.01,9.01 0001193125-25-004937 001-12111 25524716 34 194141 1 1
2024-12-05 8-K 8-K 5.02 0000950170-24-133723 001-12111 241529488 34 931604 1 1
2024-12-03 4 4 0000950170-24-132838 5051
2024-11-14 4 4 0000950170-24-127164 5067
2024-11-13 SC 13G SC 13G 0001104659-24-117751 005-46595 241454867 34 80656
2024-11-13 144 xsl144X01/primary_doc.xml 0001967940-24-000086 001-12111 241453831 33 4453
2024-11-12 4 4 0000950170-24-125616 6094
2024-11-08 144 xsl144X01/primary_doc.xml 0001965353-24-000321 001-12111 241440380 33 4943
2024-11-04 144 xsl144X01/primary_doc.xml 0001965353-24-000317 001-12111 241423390 33 6782
2024-11-01 10-Q 10-Q 0000950170-24-119796 001-12111 241417006 34 6501424 1 1
2024-11-01 8-K 8-K 2.02,9.01 0000950170-24-119795 001-12111 241416987 34 1580137 1 1
2024-10-31 SC 13G/A SEC SCHEDULE 13G 0000354204-24-004672 005-46595 241413735 34 19467
2024-10-04 3 3 0000950170-24-112963 12288
2024-09-03 4 4 0000950170-24-102887 5092
2024-08-30 144 xsl144X01/primary_doc.xml 0001965353-24-000282 001-12111 241270032 33 5505
2024-08-29 4 4 0000950170-24-101930 5129
2024-08-27 144 xsl144X01/primary_doc.xml 0001965353-24-000275 001-12111 241248964 33 4465
2024-08-13 4 4 0000950170-24-096399 7073
2024-08-09 144 xsl144X01/primary_doc.xml 0001965353-24-000253 001-12111 241193371 33 8907
2024-08-09 144 xsl144X01/primary_doc.xml 0001965353-24-000251 001-12111 241193216 33 5542
2024-08-06 10-Q 10-Q 0000950170-24-091193 001-12111 241177014 34 6585553 1 1
2024-08-06 8-K 8-K 2.02,5.02,9.01 0000950170-24-091185 001-12111 241176989 34 1602509 1 1
2024-06-17 8-K 8-K 5.02 0000950170-24-074283 001-12111 241048683 34 928713 1 1
2024-06-10 SC 13G/A PEDIATRIX MEDICAL GROUP, INC. - 05/31/2024 0001102578-24-000082 005-46595 241032100 34 10715
2024-06-04 4 4 0000950170-24-068809 5046
2024-06-04 4 4 0000950170-24-068806 9010
2024-06-04 4 4 0000950170-24-068805 5082
2024-06-04 4 4 0000950170-24-068804 6574
2024-06-04 4 4 0000950170-24-068803 6033
2024-05-30 8-K 8-K 7.01,9.01 0000950170-24-066242 001-12111 241000663 34 2688636 1 1
2024-05-13 4 4 0000950170-24-058793 4796
2024-05-13 4 4 0000950170-24-058791 4786
2024-05-13 4 4 0000950170-24-058792 4727
2024-05-13 4 4 0000950170-24-058788 4817
2024-05-13 4 4 0000950170-24-058787 4787
2024-05-13 4 4 0000950170-24-058784 4725
2024-05-13 4 4 0000950170-24-058786 4831
2024-05-13 4 4 0000950170-24-058783 4750
2024-05-09 8-K 8-K 5.07 0000950170-24-057093 001-12111 24931222 34 994856 1 1
2024-05-07 10-Q 10-Q 0000950170-24-053922 001-12111 24919552 34 5260795 1 1
2024-05-07 8-K 8-K 2.02,9.01 0000950170-24-053917 001-12111 24919511 34 1410614 1 1
2024-04-25 8-K 8-K 1.01 0000950170-24-048387 001-12111 24876883 34 932077 1 1
2024-03-28 ARS ARS 0001193125-24-079580 001-12111 24793413 34 750258
2024-03-28 DEFA14A DEFA14A 0001193125-24-079576 001-12111 24793405 34 394677
2024-03-28 DEF 14A DEF 14A 0001193125-24-079571 001-12111 24793396 34 8242088 1 1
2024-03-14 4 FORM 4 SUBMISSION 0001209191-24-004844 5842
2024-03-05 4 FORM 4 SUBMISSION 0001209191-24-004393 5892
2024-03-05 4 FORM 4 SUBMISSION 0001209191-24-004389 4926
2024-03-05 4 FORM 4 SUBMISSION 0001209191-24-004394 4928
2024-03-05 4 FORM 4 SUBMISSION 0001209191-24-004387 5918
2024-03-05 4 FORM 4 SUBMISSION 0001209191-24-004388 4965
2024-02-20 10-K 10-K 0000950170-24-016794 001-12111 24650662 34 12662002 1 1
2024-02-20 8-K 8-K 2.02,9.01 0000950170-24-016790 001-12111 24650644 34 1580785 1 1
2024-02-14 SC 13G/A SEC SCHEDULE 13G 0001532155-24-000079 005-46595 24636595 34 18387
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021688 005-46595 24629201 34 13231
2024-02-12 SC 13G/A PEDIATRIX MEDICAL GROUP, INC. - 12/31/2023 0001102578-24-000046 005-46595 24622396 34 10708
2024-02-09 SC 13G SEC SCHEDULE 13G 0000354204-24-003013 005-46595 24612240 34 19624
2024-01-22 SC 13G/A us58502b1061_012224.txt 0001086364-24-000809 005-46595 24548091 34 13674
2023-12-15 4 FORM 4 SUBMISSION 0001209191-23-058804 6604
2023-12-15 4 FORM 4 SUBMISSION 0001209191-23-058799 4653
2023-12-14 144 xsl144X01/primary_doc.xml 0001965353-23-000231 001-12111 231487248 33 4261
2023-11-02 10-Q 10-Q 0000950170-23-057738 001-12111 231369989 34 6947322 1 1
2023-11-02 8-K 8-K 2.02,9.01 0000950170-23-057732 001-12111 231369949 34 1678269 1 1
2023-08-16 UPLOAD filename1.pdf 0000000000-23-008946 39833
2023-08-08 CORRESP filename1.htm 0000950170-23-039949 36706
2023-08-03 10-Q 10-Q 0000950170-23-037565 001-12111 231137993 34 7502047 1 1
2023-08-03 8-K 8-K 2.02,9.01 0000950170-23-037559 001-12111 231137961 34 1763064 1 1
2023-07-27 UPLOAD filename1.pdf 0000000000-23-008061 43129
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037952 5225
2023-06-14 144 xsl144X01/primary_doc.xml 0001965353-23-000055 001-12111 231014074 33 4262
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035486 5729
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033878 5780
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033877 4819
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032592 5189
2023-05-24 144 xsl144X01/primary_doc.xml 0001967940-23-000008 001-12111 23953592 33 4357
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031503 7255
2023-05-19 144 xsl144X01/primary_doc.xml 0001965407-23-000002 001-12111 23941905 33 4786
2023-05-18 144 xsl144X01/primary_doc.xml 0001965353-23-000031 001-12111 23936369 33 5964
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029520 4955
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029515 4851
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029513 4906
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029516 4920
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029514 4849
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029512 5218
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029511 4938
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029430 5728
2023-05-15 4 FORM 4 SUBMISSION 0001209191-23-029419 4910
2023-05-15 3 FORM 3 SUBMISSION 0001209191-23-029403 5787
2023-05-12 144 xsl144X01/primary_doc.xml 0001969223-23-000097 001-12111 23915695 33 12838
2023-05-11 8-K 8-K 5.07 0000950170-23-021326 001-12111 23911680 34 1056638 1 1
2023-05-10 144 xsl144X01/primary_doc.xml 0001969223-23-000087 001-12111 23907881 33 9327
2023-05-10 SC 13G/A Pediatrix.htm 0001532155-23-000134 005-46595 23904965 34 18239
2023-05-04 8-K 8-K 5.02,7.01,9.01 0000950170-23-017882 001-12111 23888983 34 1212775 1 1
2023-05-02 10-Q 10-Q 0000950170-23-016430 001-12111 23876580 34 7125042 1 1
2023-05-02 8-K 8-K 2.02,9.01 0000950170-23-016427 001-12111 23876564 34 1575464 1 1
2023-03-31 ARS ARS 0001193125-23-086712 001-12111 23783179 34 1379341
2023-03-31 DEFA14A DEFA14A 0001193125-23-086708 001-12111 23783171 34 1033837
2023-03-31 DEF 14A DEF 14A 0001193125-23-086703 001-12111 23783163 34 12798129 1 1
2023-03-08 8-K 8-K 5.02 0000950170-23-006748 001-12111 23717056 34 165906 1 1
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015674 7153
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015677 6829
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015669 6836
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015672 7189
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015668 8143
2023-02-22 3 FORM 3 SUBMISSION 0001209191-23-011724 6750
2023-02-22 3 FORM 3 SUBMISSION 0001209191-23-011720 6762
2023-02-17 10-K 10-K 0000950170-23-003127 001-12111 23640256 34 15313187 1 1
2023-02-17 8-K 8-K 2.02,9.01 0000950170-23-003125 001-12111 23640247 34 1027573 1 1
2023-02-14 SC 13G/A PEDIATRIX MEDICAL GROUP, INC.- 12/31/2022 0001102578-23-000035 005-46595 23622767 34 10602
2023-02-14 SC 13G/A SEC SCHEDULE 13G 0001532155-23-000108 005-46595 23621210 34 18279
2023-02-09 SC 13G/A filing.txt 0000315066-23-001966 005-46595 23604795 34 8278
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016701 005-46595 23604018 34 13124
2023-01-23 SC 13G/A us58502b1061_012323.txt 0001306550-23-002409 005-46595 23544444 34 13394
2023-01-20 SC 13D/A AMENDMENT NO. 6 TO THE SCHEDULE 13D 0000921895-23-000157 005-46595 23541983 34 527822
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001044 4924
2022-12-16 8-K 8-K 5.02,7.01,9.01 0000950170-22-026632 001-12111 221466436 34 436751 1 1
2022-12-02 SC 13D/A AMENDMENT NO. 5 TO THE SCHEDULE 13D 0000921895-22-003156 005-46595 221443101 34 405394
2022-11-23 4 FORM 4 SUBMISSION 0001209191-22-058674 7909
2022-11-09 4 FORM 4 SUBMISSION 0001209191-22-056208 7898
2022-11-03 10-Q 10-Q 0000950170-22-021526 001-12111 221356112 34 6895348 1 1
2022-11-03 8-K 8-K 2.02,9.01 0000950170-22-021516 001-12111 221356068 34 1035447 1 1
2022-09-28 4 FORM 4 SUBMISSION 0001209191-22-051470 4828
2022-09-23 8-K FORM 8-K 5.02 0001193125-22-250187 001-12111 221262678 34 139813 1 1
2022-08-04 10-Q 10-Q 0000950170-22-014473 001-12111 221134676 34 6792208 1 1
2022-08-04 8-K 8-K 2.02,9.01 0000950170-22-014467 001-12111 221134648 34 1018928 1 1
2022-06-21 8-K 8-K 7.01,9.01 0000950170-22-011839 001-12111 221026020 34 239106 1 1
2022-05-17 8-K 8-K 5.02,5.07 0000950170-22-010201 001-12111 22935553 34 273956 1 1
2022-05-13 4 FORM 4 SUBMISSION 0001209191-22-028911 4695
2022-05-13 4 FORM 4 SUBMISSION 0001209191-22-028908 4752
2022-05-13 4 FORM 4 SUBMISSION 0001209191-22-028907 7472
2022-05-13 4 FORM 4 SUBMISSION 0001209191-22-028903 4696
2022-05-13 4 FORM 4 SUBMISSION 0001209191-22-028902 4766
2022-05-13 4 FORM 4 SUBMISSION 0001209191-22-028901 4804
2022-05-13 4 FORM 4 SUBMISSION 0001209191-22-028898 4697
2022-05-13 3 FORM 3 SUBMISSION 0001209191-22-028836 5704
2022-04-28 10-Q 10-Q 0000950170-22-006427 001-12111 22862117 34 5411421 1 1
2022-04-28 8-K 8-K 2.02,9.01 0000950170-22-006426 001-12111 22862098 34 576832 1 1
2022-04-01 DEFA14A DEFA14A 0001193125-22-093828 001-12111 22799240 34 654671
2022-04-01 DEF 14A DEF 14A 0001193125-22-093819 001-12111 22799164 34 9642281
2022-03-21 PRE 14A PRE 14A 0001193125-22-080606 001-12111 22756063 34 4797833
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015591 5217
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015594 9548
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015593 10206
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015586 9511
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015588 9543
2022-02-25 8-K 8-K 5.02 0000950170-22-002114 001-12111 22681569 34 157155 1 1
2022-02-17 10-K 10-K 0000950170-22-001387 001-12111 22645608 34 14331698 1 1
2022-02-17 8-K 8-K 2.02,9.01 0000950170-22-001386 001-12111 22645587 34 757035 1 1
2022-02-14 SC 13G/A MEDNAX.htm 0001532155-22-000037 005-46595 22630246 34 18137
2022-02-14 SC 13G/A arrowmark-md123121a2.htm 0001172661-22-000692 005-46595 22629982 34 54189
2022-02-14 8-K 8-K 1.01,2.03,7.01,9.01 0000950170-22-001148 001-12111 22625074 34 3689234 1 1
2022-02-11 SC 13G/A MEDNAX, INC. - 12/31/2021 0001102578-22-000037 005-46595 22615562 34 10446
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018074 005-46595 22610401 34 12954
2022-02-09 SC 13G filing.txt 0000315066-22-001106 005-46595 22604416 34 8309
2022-01-27 SC 13G/A us58502b1061_012722.txt 0000834237-22-002317 005-46595 22562291 34 13231
2022-01-26 SC 13G/A us58502b1061_012522.txt 0000834237-22-000880 005-46595 22555261 34 13231
2022-01-11 4 FORM 4 SUBMISSION 0001209191-22-002943 7300
2022-01-07 4 FORM 4 SUBMISSION 0001209191-22-002411 5171
2022-01-04 4 FORM 4 SUBMISSION 0001209191-22-001141 7299
2021-12-30 4 FORM 4 SUBMISSION 0001209191-21-071616 5172
2021-12-29 4 FORM 4 SUBMISSION 0001209191-21-071507 9432
2021-11-23 3 FORM 3 SUBMISSION 0001209191-21-066515 7613
2021-11-19 8-K 8-K 5.02,5.03,8.01,9.01 0000950170-21-004821 001-12111 211429477 34 394425 1 1
2021-11-10 4 FORM 4 SUBMISSION 0001209191-21-063836 5484
2021-11-10 4 FORM 4 SUBMISSION 0001209191-21-063832 5236
2021-10-29 4 FORM 4 SUBMISSION 0001209191-21-062083 5286
2021-10-29 4 FORM 4 SUBMISSION 0001209191-21-062082 4608
2021-10-28 10-Q 10-Q 0000950170-21-002406 001-12111 211355002 34 6164721 1 1
2021-10-28 8-K 8-K 2.02,9.01 0000950170-21-002405 001-12111 211354980 34 938504 1 1
2021-10-06 4 FORM 4 SUBMISSION 0001209191-21-059844 4607
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054746 5289
2021-08-31 4 FORM 4 SUBMISSION 0001209191-21-054168 10051
2021-08-31 SC 13D/A AMENDMENT NO. 4 TO THE SCHEDULE 13D 0001193805-21-001252 005-46595 211225512 34 429339
2021-08-27 8-K 8-K 8.01 0000950170-21-001577 001-12111 211219302 34 157943 1 1
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050907 5506
2021-08-06 S-8 S-8 0001193125-21-239274 333-258576 211153190 33 61669
2021-08-06 S-8 S-8 0001193125-21-239266 333-258572 211153157 33 62146
2021-08-06 10-Q 10-Q 0000950170-21-000978 001-12111 211150521 34 6108668 1 1
2021-08-06 8-K 8-K 2.02,9.01 0001193125-21-238355 001-12111 211150489 34 289970 1 1
2021-07-13 4 FORM 4 SUBMISSION 0001209191-21-046555 4620
2021-07-02 4 FORM 4 SUBMISSION 0001209191-21-045052 5189
2021-06-02 4 FORM 4 SUBMISSION 0001209191-21-037166 4885
2021-05-17 8-K 8-K 1.01 0001193125-21-163735 001-12111 21931155 34 142886 1 1
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032733 7401
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032727 7480
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032724 7526
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032719 4755
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032716 4697
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032715 7405
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032713 4707
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032709 4687
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032707 4851
2021-05-14 4 FORM 4 SUBMISSION 0001209191-21-032703 4700
2021-05-14 8-K 8-K 5.02,5.07,9.01 0001193125-21-161991 001-12111 21924526 34 181256 1 1
2021-05-07 10-Q 10-Q 0001193125-21-154019 001-12111 21900184 34 3599119 1 1
2021-05-07 8-K 8-K 2.02,9.01 0001193125-21-154005 001-12111 21900161 34 254196 1 1
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024762 6710
2021-03-23 DEFA14A DEFA14A 0001193125-21-091215 001-12111 21765034 34 977733
2021-03-23 DEF 14A DEF 14A 0001193125-21-091206 001-12111 21764999 34 7690396
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016912 9400
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016905 7506
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016899 7525
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016895 4619
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016887 9423
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016882 7528
2021-02-18 10-K 10-K 0001193125-21-047064 001-12111 21647633 34 10733094 1 1
2021-02-18 8-K 8-K 2.02,9.01 0001193125-21-047053 001-12111 21647626 34 282507 1 1
2021-02-16 SC 13G MEDNAX, INC. - 12/31/2020 0001102578-21-000040 005-46595 21637919 34 10445
2021-02-16 SC 13G/A SCHEDULE 13G HOLDINGS REPORT AMENDMENT 0001172661-21-000635 005-46595 21635613 34 54038
2021-02-12 SC 13G/A SEC SCHEDULE 13G 0000354204-21-000167 005-46595 21626342 34 19397
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-018611 005-46595 21611388 34 13823
2021-02-08 SC 13G SEC SCHEDULE 13G 0001532155-21-000026 005-46595 21597749 34 18142
2021-01-26 SC 13G/A us58502b1061_012621.txt 0000834237-21-001403 005-46595 21553352 34 13212
2021-01-05 4 FORM 4 SUBMISSION 0001209191-21-001146 7332
2020-12-21 8-K FORM 8-K 2.01,2.04,7.01,8.01,9.01 0001193125-20-323140 001-12111 201404603 34 427037 1 1
2020-12-11 4 FORM 4 SUBMISSION 0001209191-20-062948 10802
2020-12-10 SC 13G/A SCHEDULE 13G/A 0001104659-20-133976 005-46595 201379630 34 13820
2020-11-24 8-K 8-K 8.01 0001193125-20-302610 001-12111 201344354 34 145584 1 1
2020-11-06 10-Q 10-Q 0001193125-20-287356 001-12111 201292365 34 5611995 1 1
2020-11-06 8-K FORM 8-K 2.02,9.01 0001193125-20-287348 001-12111 201292349 34 281377 1 1
2020-10-02 3 FORM 3 SUBMISSION 0001209191-20-053152 8774
2020-10-02 4 FORM 4 SUBMISSION 0001209191-20-053146 4769
2020-09-29 3 FORM 3 SUBMISSION 0001209191-20-052408 10991
2020-09-29 8-K 8-K 5.02 0001193125-20-257929 001-12111 201209653 34 150590 1 1
2020-09-29 4 FORM 4 SUBMISSION 0001209191-20-052356 8085
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-050960 5223
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-050955 5082
2020-09-15 8-K 8-K 1.01,5.07,9.01 0001193125-20-245502 001-12111 201174533 34 957065 1 1
2020-09-10 8-K 8-K 7.01,8.01,9.01 0001193125-20-242587 001-12111 201167714 34 182444 1 1
2020-08-25 8-K 8-K 5.02,7.01,9.01 0001193125-20-229109 001-12111 201129541 34 176375 1 1
2020-07-30 10-Q 10-Q 0001193125-20-203325 001-12111 201059128 34 4724864 1 1
2020-07-30 8-K 8-K 2.02,9.01 0001193125-20-203317 001-12111 201059101 34 286649 1 1
2020-07-28 DEFA14A DEFA14A 0001193125-20-201012 001-12111 201054179 34 95553
2020-07-28 DEF 14A DEF 14A 0001193125-20-200999 001-12111 201054068 34 3102442
2020-07-15 4 FORM 4 SUBMISSION 0001209191-20-042535 7605
2020-07-15 3 FORM 3 SUBMISSION 0001209191-20-042533 6292
2020-07-14 4 FORM 4 SUBMISSION 0001209191-20-042457 7526
2020-07-14 4 FORM 4 SUBMISSION 0001209191-20-042456 7651
2020-07-14 4 FORM 4 SUBMISSION 0001209191-20-042455 12746
2020-07-14 4 FORM 4 SUBMISSION 0001209191-20-042453 7530
2020-07-14 4 FORM 4 SUBMISSION 0001209191-20-042451 4765
2020-07-14 4 FORM 4 SUBMISSION 0001209191-20-042448 4723
2020-07-14 4 FORM 4 SUBMISSION 0001209191-20-042446 4705
2020-07-14 3 FORM 3 SUBMISSION 0001209191-20-042445 6214
2020-07-14 3 FORM 3 SUBMISSION 0001209191-20-042444 6340
2020-07-14 3 FORM 3 SUBMISSION 0001209191-20-042443 5716
2020-07-14 3 FORM 3 SUBMISSION 0001209191-20-042442 6217
2020-07-13 SC 13D/A AMENDMENT NO. 3 TO THE SCHEDULE 13D 0000921895-20-001971 005-46595 201025858 34 759509
2020-07-13 DEFA14A DEFA14A 0001193125-20-191604 001-12111 201024420 34 354265
2020-07-13 8-K FORM 8-K 1.01,5.02,7.01,9.01 0001193125-20-191602 001-12111 201024416 34 587007 1 1
2020-07-10 SC 13G/A us58502b1061_071020.txt 0000834237-20-010000 005-46595 201022171 34 13371
2020-06-15 DEFA14A DEFA14A 0001193125-20-168100 001-12111 20961775 34 21715
2020-06-15 8-K 8-K 8.01 0001193125-20-168098 001-12111 20961774 34 149265 1 1
2020-06-05 DEFA14A DEFA14A 0001193125-20-161343 001-12111 20944639 34 59319
2020-06-05 8-K 8-K 7.01,8.01,9.01 0001193125-20-161340 001-12111 20944637 34 199244 1 1
2020-06-03 4 FORM 4 SUBMISSION 0001209191-20-034030 4847
2020-06-03 4 FORM 4 SUBMISSION 0001209191-20-034023 4921
2020-06-03 4 FORM 4 SUBMISSION 0001209191-20-034017 4693
2020-06-03 4 FORM 4 SUBMISSION 0001209191-20-034009 4674
2020-05-15 SC 13D/A AMENDMENT NO. 2 TO THE SCHEDULE 13D 0001193805-20-000593 005-46595 20880889 34 633568
2020-05-12 8-K 8-K 1.01,2.01,9.01 0001193125-20-140531 001-12111 20869693 34 975523 1 1
2020-05-07 10-Q 10-Q 0001193125-20-136311 001-12111 20856868 34 5665295 1 1
2020-05-07 8-K 8-K 2.02,9.01 0001193125-20-135547 001-12111 20854483 34 247205 1 1
2020-05-06 8-K 8-K 7.01,8.01,9.01 0001193125-20-134447 001-12111 20851434 34 213563 1 1
2020-04-28 10-K/A FORM 10-K/A 0001193125-20-123354 001-12111 20826182 34 2652158 1 1
2020-04-07 8-K 8-K 5.02 0001193125-20-100475 001-12111 20779891 34 143556 1 1
2020-03-25 8-K 8-K 1.01,2.03,7.01,8.01,9.01 0001564590-20-012671 001-12111 20739948 34 218272 1 1
2020-03-09 8-K 8-K 8.01 0001193125-20-067220 001-12111 20698347 34 141914 1 1
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015322 9084
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015316 4694
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015304 4692
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015297 9099
2020-03-02 SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-20-000633 005-46595 20678423 34 614856
2020-02-20 8-K 8-K 2.02,9.01 0001193125-20-042625 001-12111 20632503 34 295164 1 1
2020-02-20 10-K 10-K 0001193125-20-042622 001-12111 20632501 34 13549372 1 1
2020-02-19 3 FORM 3 SUBMISSION 0001209191-20-010748 9817
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010338 4790
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010334 4753
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010333 4816
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010332 5665
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010331 4758
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010330 5472
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010328 4870
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010327 4748
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010326 5758
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010324 5471
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010322 4912
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010321 4761
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010320 5454
2020-02-18 4 FORM 4 SUBMISSION 0001209191-20-010319 4811
2020-02-18 SEC STAFF LETTER filename1.pdf 9999999997-20-000740 227078
2020-02-14 SC 13G SCHEDULE 13G HOLDINGS REPORT 0001172661-20-000893 005-46595 20621122 34 54007
2020-02-14 SC 13G/A md13gadec19.txt 0000080255-20-001019 005-46595 34 7005
2020-02-14 DFAN14A dfan14a06297280_02132020.htm 0000921895-20-000456 001-12111 20613201 34 565100
2020-02-13 SC 13D SCHEDULE 13D 0000921895-20-000442 005-46595 20612231 34 813408

Latest XBRL company facts

One latest value per concept from companyfacts (536 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 78.12M 2026-10-27 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
dei EntityPublicFloat Entity Public Float USD 899.92M 2025-06-30 2025 FY 10-K 2026-02-19 0001193125-26-058074
srt StockRepurchaseProgramAuthorizedAmount1 StockRepurchaseProgramAuthorizedAmount1 USD 250.00M 2025-08-31 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AcceleratedShareRepurchasesSettlementPaymentOrReceipt Accelerated Share Repurchases, Settlement (Payment) or Receipt USD 200.00M 2015-03-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 342.86M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 25.89M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 1.34B 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 231.82M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AccretionExpense Accretion Expense USD 1.32M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-31 0001193125-13-420886
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 194.12M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 132.34M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.74M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 886.88M 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 850.57M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 3.20M 2016-04-01 2016-06-30 2016 Q2 10-Q 2016-07-28 0001193125-16-662264
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 6.20M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD 4.20M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.70M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-05 0001193125-26-204993
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 20.00M 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-01 0001193125-11-290716
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 1.08B 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 214,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 5.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 91,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AssetAcquisitionContingentConsiderationLiability AssetAcquisitionContingentConsiderationLiability USD 3.50M 2025-09-30 2025 Q3 10-Q 2025-11-03 0001193125-25-261640
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap Assets Assets USD 2.14B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AssetsCurrent Assets, Current USD 684.08M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 46.00M 2017-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 23.50M 2017-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther Assets Held-for-sale, Not Part of Disposal Group, Current, Other USD 22.50M 2017-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 691.18M 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2020-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 98.51M 2021-09-30 2021 Q3 10-Q 2021-10-28 0000950170-21-002406
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 74.51M 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 113.92M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 113.92M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap BuildingsAndImprovementsGross Buildings and Improvements, Gross USD 8.29M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap BusinessAcquisitionContingentConsiderationAtFairValue Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) USD 6.10M 2012-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196162
us-gaap BusinessAcquisitionContingentConsiderationPotentialCashPayment Business Acquisition, Contingent Consideration, Potential Cash Payment (Deprecated 2013-01-31) USD 0 2012-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap BusinessAcquisitionCostOfAcquiredEntityCashPaid Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) USD 26.80M 2012-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196162
us-gaap BusinessAcquisitionCostOfAcquiredEntityPurchasePrice Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) USD 32.90M 2012-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196162
us-gaap BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned Business Acquisition, Equity Interest Issued or Issuable, Value Assigned USD 2.70M 2017-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 69,014 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap BusinessAcquisitionPreexistingRelationshipGainLossRecognized Business Acquisition, Preexisting Relationship, Gain (Loss) Recognized (Deprecated 2014-01-31) USD 0 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389697
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares 3.57 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap BusinessAcquisitionProFormaEarningsPerShareDiluted Business Acquisition, Pro Forma Earnings Per Share, Diluted USD/shares 3.54 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets (Deprecated 2013-01-31) USD 8.30M 2012-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196162
us-gaap BusinessAcquisitionPurchasePriceAllocationCapitalLeaseObligationAccrual Business Acquisition, Purchase Price Allocation, Capital Lease Obligation Accrual (Deprecated 2013-01-31) USD 2.00M 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities Business Acquisition, Purchase Price Allocation, Current Liabilities (Deprecated 2013-01-31) USD 1.40M 2012-06-30 2012 Q2 10-Q 2012-07-31 0001193125-12-325900
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillAmount Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) USD 24.60M 2012-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196162
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount Business Acquisition, Goodwill, Expected Tax Deductible Amount USD 7.50M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap BusinessAcquisitionPurchasePriceAllocationOtherLiabilities Business Acquisition, Purchase Price Allocation, Other Liabilities (Deprecated 2013-01-31) USD 12.00M 2012-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment (Deprecated 2013-01-31) USD 600,000 2012-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD 329.72M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 3.34B 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 47.00M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap BusinessCombinationConsiderationTransferredLiabilitiesIncurred Business Combination, Consideration Transferred, Liabilities Incurred USD 2.40M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-07-31 0001193125-14-289739
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (Deprecated 2013-01-31) USD 37.50M 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196162
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 5.30M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High USD 4.10M 2016-06-30 2016 Q2 10-Q 2016-07-28 0001193125-16-662264
us-gaap BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low USD 0 2016-06-30 2016 Q2 10-Q 2016-07-28 0001193125-16-662264
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 3.50M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 8.50M 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized Business Combination, Liabilities Arising from Contingencies, Amount Recognized USD 20.00M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets USD 11.80M 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389697
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other USD 300,000 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities USD 14.40M 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389697
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other USD 400,000 2015-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent USD 23.90M 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389697
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 400,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other USD 14.20M 2016-06-30 2016 Q2 10-Q 2016-07-28 0001193125-16-662264
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets USD 900,000 2016-06-30 2016 Q2 10-Q 2016-07-28 0001193125-16-662264
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 400,000 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 346.80M 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389697
us-gaap BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses Business Combination, Separately Recognized Transactions, Net Gains and Losses USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1 Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value USD 7.70M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage pure 0.75 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 1.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 441,000 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 253,000 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 188,000 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 334,000 2012-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 253,000 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 63,000 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 74,000 2017-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 74,000 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 114,000 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 15.00M 2016-01-01 2016-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 311.92M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations USD 1.12B 2020-12-31 2021 Q3 10-Q 2021-10-28 0000950170-21-002406
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 13.60M 2016-06-30 2016 Q2 10-Q 2016-07-28 0001193125-16-662264
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -19.26M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001193125-18-152850
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 112.77M 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 311.92M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -63.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations Cash Provided by (Used in) Financing Activities, Discontinued Operations USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD -1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap CashSurrenderValueFairValueDisclosure Cash Surrender Value, Fair Value Disclosure USD 10.50M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap CashSurrenderValueOfLifeInsurance Cash Surrender Value of Life Insurance USD 16.30M 2018-09-30 2018 Q3 10-Q 2018-11-01 0001193125-18-315785
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 78.09M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 78.09M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap CommonStockValue Common Stock, Value, Issued USD 781,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 114.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap ContingentConsiderationClassifiedAsEquityFairValueDisclosure Contingent Consideration Classified as Equity, Fair Value Disclosure USD 700,000 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap ContractualObligation Contractual Obligation USD 596.88M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 400.00M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 25.00M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 171.88M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 1.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -2.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD 600.26M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 596.88M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 1.28B 2015-12-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.054 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible Decrease in Unrecognized Tax Benefits is Reasonably Possible USD 1.10M 2017-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 39.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 45.16M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 33.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 170.39M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 61.43M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap DeferredOtherTaxExpenseBenefit Deferred Other Tax Expense (Benefit) USD 10.80M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 12.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 14.15M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 24.20M 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 216.94M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 16.90M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 132.78M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001193125-20-136311
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 187.29M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 45.96M 2014-12-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 118.41M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 332.50M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 23.10M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.23M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 1.69M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.57M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 6.51M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 62.70M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 29.65M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 7.30M 2020-12-31 2021 FY 10-K 2022-02-17 0000950170-22-001387
us-gaap DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals USD 39,000 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 162.18M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 8.18M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 61.98M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001193125-20-136311
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 24,000 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 128,000 2011-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 29.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap Depreciation Depreciation USD 14.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 18.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 38.54M 2008-01-01 2008-12-31 2010 FY 10-K 2011-02-24 0001193125-11-045579
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax USD -372.97M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-01 0001193125-19-281135
us-gaap DiscontinuedOperationTaxEffectOfDiscontinuedOperation Discontinued Operation, Tax Effect of Discontinued Operation USD -49.02M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-01 0001193125-19-281135
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net USD 38.12M 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current USD 23.77M 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents USD 0 2020-03-31 2020 Q1 10-Q 2020-05-07 0001193125-20-136311
us-gaap DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets Disposal Group, Including Discontinued Operation, Deferred Tax Assets USD 13.01M 2019-09-30 2019 Q3 10-Q 2019-11-01 0001193125-19-281135
us-gaap DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilitiesCurrent Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities, Current USD 35.66M 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization Disposal Group, Including Discontinued Operation, Depreciation and Amortization USD 7.26M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-01 0001193125-19-281135
us-gaap DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense Disposal Group, Including Discontinued Operation, General and Administrative Expense USD 33.45M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-01 0001193125-19-281135
us-gaap DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent Disposal Group, Including Discontinued Operation, Goodwill, Current USD 321.56M 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent Disposal Group, Including Discontinued Operation, Intangible Assets, Current USD 275.15M 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingExpense Disposal Group, Including Discontinued Operation, Operating Expense USD 528.24M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-01 0001193125-19-281135
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss Disposal Group, Including Discontinued Operation, Operating Income (Loss) USD 20.10M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherExpense Disposal Group, Including Discontinued Operation, Other Expense USD 47,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-01 0001193125-19-281135
us-gaap DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current USD 2.50M 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current USD 42.60M 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 172.70M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 36.40M 2020-07-01 2020-09-30 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 1.47 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 1.43 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.236 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure -0.124 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0.379 2012-01-01 2012-12-31 2013 FY 10-K 2014-02-12 0001193125-14-045903
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -3.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.043 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 16.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 49.86M 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 18.00M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap EquityMethodInvestmentDividendsOrDistributions Proceeds from Equity Method Investment, Distribution USD 2.63M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.49 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 4.24M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 41.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 3.38M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1.81M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 1.58M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 57.84M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 6.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FiniteLivedIntangibleAssetsAmortizationExpense Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) USD 10.30M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 229.30M 2015-12-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 6.43M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 811,000 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 914,000 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 1.77M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 2.72M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FiniteLivedIntangibleAssetsFutureAmortizationExpense Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) USD 17.30M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 74.70M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 13.10M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap FiniteLivedIntangibleAssetsPeriodIncreaseDecrease Finite-Lived Intangible Assets, Period Increase (Decrease) USD 226.10M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap FiniteLivedIntangibleAssetsUsefulLifeMaximum Finite-Lived Intangible Assets, Useful Life, Maximum (Deprecated 2012-01-31) pure 20 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap FiniteLivedIntangibleAssetsUsefulLifeMinimum Finite-Lived Intangible Assets, Useful Life, Minimum (Deprecated 2012-01-31) pure 1 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap FiniteLivedIntangibleAssetsWeightedAverageUsefulLife Finite-Lived Intangible Assets, Weighted-Average Useful Life (Deprecated 2012-01-31) pure 2.9 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap FixturesAndEquipmentGross Fixtures and Equipment, Gross USD 161.20M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap FutureAmortizationExpenseYearFive Future Amortization Expense, Year Five (Deprecated 2012-01-31) USD 5.70M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap FutureAmortizationExpenseYearFour Future Amortization Expense, Year Four (Deprecated 2012-01-31) USD 8.00M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap FutureAmortizationExpenseYearOne Future Amortization Expense, Year One (Deprecated 2012-01-31) USD 12.50M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap FutureAmortizationExpenseYearThree Future Amortization Expense, Year Three (Deprecated 2012-01-31) USD 10.10M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap FutureAmortizationExpenseYearTwo Future Amortization Expense, Year Two (Deprecated 2012-01-31) USD 11.70M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 20.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap GainLossOnSaleOfProperties Gain (Loss) on Sale of Properties USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 184.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap Goodwill Goodwill USD 1.27B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 7.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 1.45B 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 150.64M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 99.00M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap GoodwillTransfers Goodwill, Transfers USD 7.20M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap HealthCareOrganizationLossContractsExpense Health Care Organization, Loss Contracts Expense (Deprecated 2016-01-31) USD 3.36B 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap HealthCareOrganizationPatientServiceRevenue Health Care Organization, Patient Service Revenue (Deprecated 2018-01-31) USD 756.37M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001193125-18-152850
us-gaap HealthCareOrganizationRevenue Health Care Organization, Revenue (Deprecated 2018-01-31) USD 901.86M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001193125-18-152850
us-gaap HealthCareTrustFundAdministrativeExpense Health Care Trust Fund, Administrative Expense (Deprecated 2016-01-31) USD -98.83M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap HeldToMaturitySecuritiesCurrent Debt Securities, Held-to-maturity, Current USD 85.04M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001193125-20-136311
us-gaap HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 2.12M 2017-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 69.70M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap HeldToMaturitySecuritiesNoncurrent Debt Securities, Held-to-maturity, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap ImpairmentChargeOnReclassifiedAssets Impairment Charge on Reclassified Assets USD 7.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 7.70M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 27.79M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 20.10M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 202.69M 2010-01-01 2010-12-31 2010 FY 10-K 2011-02-24 0001193125-11-045579
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 157.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 104.36M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-01 0001193125-14-177190
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -99.07M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -1.19 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -1.19 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 3.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncomeTaxesPaid Income Taxes Paid USD 4.70M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 0 2022-12-31 2022 FY 10-K 2023-02-17 0000950170-23-003127
us-gaap IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear Income Tax Examination, Increase (Decrease) in Liability from Prior Year USD 600,000 2015-12-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 300,000 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 41.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 147.26M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD -70.00M 2017-10-01 2017-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 321,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 1.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 8.47M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 45.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 3.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 12.50M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 451,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -662,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -1.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 151,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 9.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap IncomeTaxReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Amount USD 600,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-12 0001193125-14-045903
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -74.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 2.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 5.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 13.90M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 53.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncreaseDecreaseInFuturePolicyBenefitReserves Increase (Decrease) in Future Policy Benefit Reserves USD 11.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-17 0000950170-23-003127
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 10.90M 2010-07-01 2010-09-30 2011 Q3 10-Q 2011-11-01 0001193125-11-290716
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD -799,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021526
us-gaap IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve USD -3.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -15.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -1.16M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-04-28 0001193125-16-563830
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -11.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -3.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible Increase in Unrecognized Tax Benefits is Reasonably Possible USD 2.20M 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 2.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap InsuranceSettlementsReceivable Insurance Settlements Receivable USD 28.50M 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 671.74M 2016-09-30 2016 Q3 10-Q 2016-10-27 0001193125-16-749764
us-gaap InterestExpense Interest Expense USD 20.91M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-06 0000950170-24-091193
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 24.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 2.56M 2010-01-01 2010-12-31 2010 FY 10-K 2011-02-24 0001193125-11-045579
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 34.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap InterestPayableCurrent Interest Payable, Current USD 2.77M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap InvestmentBuildingAndBuildingImprovements Investment Building and Building Improvements USD 18.50M 2011-06-30 2011 Q2 10-Q 2011-08-02 0001193125-11-206395
us-gaap InvestmentIncomeNet Investment Income, Net USD 15.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 20.00M 2021-12-31 2022 FY 10-K 2023-02-17 0000950170-23-003127
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 419.60M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-04-30 0001193125-15-161981
us-gaap Land Land USD 2.03M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 42.90M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap LeaseCost Lease, Cost USD 17.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 41.03M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.94M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 12.43M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.90M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.71M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 7.85M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 11.20M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 4.67M 2019-09-30 2019 Q3 10-Q 2019-11-01 0001193125-19-281135
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 3.75M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 200,000 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap Liabilities Liabilities USD 1.29B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 2.14B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap LiabilitiesCurrent Liabilities, Current USD 535.73M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 59.43M 2018-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2020-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 7.00M 2015-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap LiabilityForUncertainTaxPositionsNoncurrent Liability for Uncertainty in Income Taxes, Noncurrent USD 3.50M 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap LineOfCredit Long-term Line of Credit USD 80.00M 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-053922
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 144.00M 2012-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod Line of Credit Facility, Maximum Amount Outstanding During Period USD 650.50M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 37.50M 2020-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 450.00M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap LongTermDebt Long-term Debt USD 611.20M 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 397.77M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 179.95M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 20.00M 2016-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 750.00M 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 20.00M 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 130.00M 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 0 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 130.00M 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 30.00M 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.68B 2016-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap LongtermDebtWeightedAverageInterestRate Long-term Debt, Weighted Average Interest Rate, at Point in Time pure 0.009 2013-12-31 2013 FY 10-K 2014-02-12 0001193125-14-045903
us-gaap LongTermInvestments Long-term Investments USD 0 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 368.50M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001193125-20-136311
us-gaap MalpracticeLossContingencyAccrualNotRecognized Malpractice Loss Contingency, Accrual Not Recognized (Deprecated 2012-01-31) USD 79.50M 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap MalpracticeLossContingencyAccrualNotRecognizedHighEndOfLossRange Malpractice Loss Contingency, Accrual Not Recognized, High End of Loss Range (Deprecated 2016-01-31) USD 8.50M 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap MalpracticeLossContingencyAccrualUndiscounted Malpractice Loss Contingency, Accrual, Undiscounted USD 287.90M 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap MalpracticeLossContingencyAccrualUndiscountedCurrent Malpractice Loss Contingency, Accrual, Undiscounted, Current USD 33.90M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap MalpracticeLossContingencyAccrualUndiscountedNoncurrent Malpractice Loss Contingency, Accrual, Undiscounted, Noncurrent USD 235.50M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap MalpracticeLossContingencyClaimsIncurredInPeriod Malpractice Loss Contingency, Claims Incurred in Period USD 47,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap MalpracticeLossContingencyClaimsIncurredInPriorPeriods Malpractice Loss Contingency, Claims Incurred in Prior Periods USD 42.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap MalpracticeLossContingencyClaimsIncurredNet Malpractice Loss Contingency, Claims Incurred, Net USD 42.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap MalpracticeLossContingencyPeriodIncreaseDecrease Malpractice Loss Contingency, Period Increase (Decrease) USD -643,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-04 0001193125-18-152850
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2022-12-31 2022 FY 10-K 2023-02-17 0000950170-23-003127
us-gaap MinorityInterestOwnershipPercentageByParent Noncontrolling Interest, Ownership Percentage by Parent pure 0.75 2015-06-30 2015 Q2 10-Q 2015-07-30 0001193125-15-270938
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 300,000 2018-09-30 2018 Q3 10-Q 2018-11-01 0001193125-18-315785
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD -22,000 2008-01-01 2008-12-31 2010 FY 10-K 2011-02-24 0001193125-11-045579
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -165.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -25.71M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -10.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -48.18M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 112.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 114.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 116.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 500,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-11 0001193125-16-459842
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 232,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-17 0000950170-23-003127
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -5.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap NumberOfBusinessesAcquired Number of Businesses Acquired Acquisition 15 2016-01-01 2016-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OperatingExpenses Operating Expenses USD 1.30B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 163.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OperatingLeaseCost Operating Lease, Cost USD 11.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 12.50M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 37.28M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 11.02M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 23.26M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OperatingLeasePayments Operating Lease, Payments USD 20.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 31.13M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 103.48M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 30.82M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 9.44M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 12.71M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 17.95M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 22.04M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 10.52M 2018-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.059 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 355.60M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 49.36M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OtherAssetsCurrent Other Assets, Current USD 8.96M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 37.29M 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 57.89M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 218,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-057738
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent USD 100,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-057738
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.35M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OtherEmployeeRelatedLiabilitiesCurrent Other Employee-related Liabilities, Current USD 42.90M 2014-06-30 2014 Q2 10-Q 2014-07-31 0001193125-14-289739
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 198.14M 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap OtherLiabilities Other Liabilities USD 21.70M 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap OtherLiabilitiesFairValueDisclosure Other Liabilities, Fair Value Disclosure USD 36.10M 2012-09-30 2012 Q3 10-Q 2012-11-01 0001193125-12-446668
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 36.12M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 3.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PaymentForContingentConsiderationLiabilityOperatingActivities Payment for Contingent Consideration Liability, Operating Activities USD 318,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001193125-25-261640
us-gaap PaymentsForPreviousAcquisition Payments for Previous Acquisition USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD -526,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 147.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 1.76M 2008-01-01 2008-12-31 2010 FY 10-K 2011-02-24 0001193125-11-045579
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 31.20M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-01 0001193125-19-281135
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 7.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 19.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PaymentsToAcquireOtherPropertyPlantAndEquipment Payments to Acquire Other Property, Plant, and Equipment USD 12.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 8.98M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment USD 99.80M 2010-01-01 2010-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ProceedsAndExcessTaxBenefitFromSharebasedCompensation Proceeds and Excess Tax Benefit from Share-based Compensation USD 1.70M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-17 0000950170-22-001387
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 249.70M 2019-10-10 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap ProceedsFromIssuanceOfSeniorLongTermDebt Proceeds from Issuance of Senior Long-term Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-17 0000950170-23-003127
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD -699,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap ProceedsFromSaleAndMaturityOfOtherInvestments Proceeds from Sale and Maturity of Other Investments USD 27.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 18.38M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-102382
us-gaap ProceedsFromSaleOfBuildings Proceeds from Sale of Buildings USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap ProceedsFromSaleOfInvestmentProjects Proceeds from Sale of Investment Projects USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap ProceedsFromSaleOfOtherProductiveAssets Proceeds from Sale of Other Productive Assets USD 6.83M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ProceedsFromSaleOfOtherPropertyPlantAndEquipment Proceeds from Sale of Other Property, Plant, and Equipment USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-28 0000950170-21-002406
us-gaap ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets Proceeds from Sales of Business, Affiliate and Productive Assets USD 1.08M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 165.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ProFormaWeightedAverageSharesOutstandingDiluted Pro Forma Weighted Average Shares Outstanding, Diluted shares 93.11M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 171.51M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 37.24M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 1.80M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-28 0000950170-21-002406
us-gaap RepaymentsOfLongTermDebtAndCapitalSecurities Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security USD 262,000 2010-01-01 2010-12-31 2010 FY 10-K 2011-02-24 0001193125-11-045579
us-gaap RepaymentsOfSeniorDebt Repayments of Senior Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 20.00M 2017-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD 1.10M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap RestructuringCharges Restructuring Charges USD 19.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 1.47B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap SalesRevenueGoodsNetPercentage Sales Revenue, Goods, Net, Percentage (Deprecated 2013-01-31) pure 1 2012-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap SelfInsuranceReserveCurrent Self Insurance Reserve, Current USD 179.40M 2024-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 15.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 89,842 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value (Deprecated 2012-01-31) USD 54.58 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 12.86 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.42M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 13.94 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1.70M 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 10.53 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 987,593 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 9.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 17.29 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2011-01-01 2011-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.5 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.37 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.32 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.019 2011-01-01 2011-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.023 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.021 2010-01-01 2010-12-31 2012 FY 10-K 2013-02-15 0001193125-13-062738
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 4.50M 2017-03-31 2017 Q1 10-Q 2017-05-04 0001193125-17-158793
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 0 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 16.91 2022-12-31 2022 FY 10-K 2023-02-17 0000950170-23-003127
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 4.5 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.70M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-17 0000950170-22-001387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) USD 44.42 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 887,731 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value USD/shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-17 0000950170-22-001387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 500 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) USD 37.59 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 41,400 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-17 0000950170-23-003127
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) USD 72.5 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.21 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-18 0001193125-21-047064
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 0 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 16.91 2022-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 4.8 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 900,000 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 1.3 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 16.91 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 36.25 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-17 0000950170-22-001387
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 27.72 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap ShareRepurchaseProgramExciseTax ShareRepurchaseProgramExciseTax USD 830,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 50.00M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-04-28 0000950170-22-006427
us-gaap ShortTermInvestments Short-term Investments USD 0 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 9.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 849.62M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 849.62M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 2 2013-12-19 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap StockIssued1 Stock Issued USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-20 0001193125-20-042622
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021526
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-17 0000950170-23-003127
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 678,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 18.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 4.91M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 22.53M 2010-01-01 2010-12-31 2010 FY 10-K 2011-02-24 0001193125-11-045579
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 83.04M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 500.00M 2018-08-31 2024 Q1 10-Q 2024-05-07 0000950170-24-053922
us-gaap StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Number of Shares Authorized to be Repurchased shares 61,000 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 Stock Repurchase Program, Remaining Authorized Repurchase Amount USD 21.50M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 2.98M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -2.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.02M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 3.67M 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-09 0001193125-15-039201
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 1.04M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-17 0000950170-22-001387
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 5.64M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-14 0001193125-19-040891
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 7.70M 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089192
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 70,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-016794
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense Unrecognized Tax Benefits, Interest on Income Taxes Expense USD 4.70M 2010-07-01 2010-09-30 2011 Q3 10-Q 2011-11-01 0001193125-11-290716
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 600,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 1.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 1.00M 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 395.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap ValuationAllowancesAndReservesAdjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment USD -8.22M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-14 0001193125-18-045748
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 1.08B 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 6.18B 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD -6.22B 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-023730
us-gaap VariableLeaseCost Variable Lease, Cost USD 4.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001193125-26-058074
us-gaap WeightedAverageBasicSharesOutstandingProForma Weighted Average Basic Shares Outstanding, Pro Forma shares 92.42M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-10 0001193125-17-038250
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 81.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 79.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001193125-26-436952

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →